about
Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitorsReview article: bismuth-based therapy for Helicobacter pylori eradication in childrenEnteric coating can lead to reduced antiplatelet effect of low-dose acetylsalicylic acidUrinary excretion of salicyluric and salicylic acids by non-vegetarians, vegetarians, and patients taking low dose aspirinAge-related difference in susceptibility of Apc(Min/+) mice towards the chemopreventive efficacy of dietary aspirin and curcuminSalicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureusDietary salicylatesEffect of salicylic acid on invasion of human vascular endothelial cells by Staphylococcus aureusAspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cellsSalicylate poisoning: an evidence-based consensus guideline for out-of-hospital managementSalicylic Acid Conjugated Dendrimers Are a Tunable, High Performance CEST MRI NanoPlatformSpatiotemporal integration of molecular and anatomical data in virtual reality using semantic mapping.Development and validation of a high-performance liquid chromatography method for the simultaneous determination of aspirin and folic acid from nano-particulate systems.Salicylic acid sans aspirin in animals and man: persistence in fasting and biosynthesis from benzoic acidA Novel NF-κB Inhibitor, Edasalonexent (CAT-1004), in Development as a Disease-Modifying Treatment for Patients With Duchenne Muscular Dystrophy: Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics in Adult SubjectsPharmacometabolomics reveals that serotonin is implicated in aspirin response variabilityLack of pharmacokinetic interaction between the oral anti-influenza prodrug oseltamivir and aspirin.The influence of gastrointestinal transit on drug absorption in healthy volunteersLow dose aspirin estimation: an application to a human pharmacokinetic study.Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Determinants of aspirin metabolism in healthy men and women: effects of dietary inducers of UDP-glucuronosyltransferasesIntracellular erythrocyte platelet-activating factor acetylhydrolase I inactivates aspirin in blood.Inhibition of phenolsulphotransferase by salicylic acid: a possible mechanism by which aspirin may reduce carcinogenesis.Comparison of three aspirin formulations in human volunteers.The Influence of Efflux Pump Inhibitors on the Activity of Non-Antibiotic NSAIDS against Gram-Negative Rods.Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations.Aspirin hydrolysis in plasma is a variable function of butyrylcholinesterase and platelet-activating factor acetylhydrolase 1b2 (PAFAH1b2)Drug metabolite profiling and elucidation of drug-induced hepatotoxicity.Effect of common single-nucleotide polymorphisms in acetylsalicylic acid metabolic pathway genes on platelet reactivity in patients with diabetes.Benzoate- and Salicylate-Tolerant Strains of Escherichia coli K-12 Lose Antibiotic Resistance during Laboratory Evolution.Antiplatelet therapy and vascular disease: an update.Manifold beneficial effects of acetyl salicylic acid and nonsteroidal anti-inflammatory drugs on sepsis.Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance, and application in clinical practice.Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events.The aspirin metabolite salicylate inhibits lysine acetyltransferases and MUC1 induced epithelial to mesenchymal transition.Drug-disease interactions: narrative review of aspirin in gastric ulcer.A critical review of the literature to conduct a toxicity assessment for oral exposure to methyl salicylate.Absorption of salicylate powders versus tablets following overdose: a poison center observational study.Salicylate measurement: clinical usefulness and methodology.
P2860
Q24298832-3356F65F-FF14-4B54-8A16-6FAE56B4EDCFQ26998597-6C232997-ABDB-4BEC-A81A-847B41BF320FQ27015913-57AC8346-9ECB-4D1B-A97F-7EDC8928BA5CQ28165161-A70A4662-30F2-4EF6-A311-CC2E362E6BDBQ28196338-06BD57CC-ED99-4FC7-8A50-4387B3A5C290Q28196747-544C155E-DE9D-42C0-8A52-E857545B29EDQ28209075-93F2A88F-5588-47E9-B890-7C3514E05F8EQ28210008-778A1B23-1B71-486B-ADD8-3FB3785A3377Q28217990-F0BAD0EE-A9A0-4785-A4B1-480EECC43830Q28221052-48889C80-90F4-4E93-BED8-17264EDADD7EQ31048798-167EC5FA-7329-4BC4-AFC5-50299F16BEA8Q33440612-BB4FD8B5-08CD-4465-A433-8F547437CCC9Q33520725-783AA55F-E844-45A3-B133-733CEF3B9AD9Q33567471-1318892A-6021-45E4-AEA8-F895635F9471Q33625958-A93706ED-639E-4A9C-A5E9-5348177D14E1Q33994559-10A6B3CC-FF5D-4BCE-B2D8-E03945A260DFQ34109232-8934E9EC-08AD-434C-8D64-21CDCA086DDFQ34403115-12B8697D-3ECB-41A0-B73C-BB8F2EE3E968Q34451727-EDAB319C-20D9-4E71-90B4-8358CC3DE75CQ34771381-3818EA9A-5038-4FE1-AFBC-8783AE607C8CQ35063581-12D03236-F4E8-44BA-B07C-FF7116C0753EQ35266471-20A0CE09-491C-4AB4-BBD2-6827A43ADFC9Q35349506-485AE9A9-2B61-41F3-825D-D3D1C8BBF494Q35608241-0BCAA262-80E6-4B17-8038-2D50F9284E2EQ35895154-C5278FB0-5A7F-4B27-B0FE-FAC6443998F6Q36402212-EB4D4E5C-E550-4CDA-B663-4993883BFB7EQ36544972-240E1626-3763-4678-BA29-220725EF1E7AQ36796842-7F3B2A1E-07C2-4F23-9DD7-81EA60558EA1Q36835826-9F0E3E85-8EAF-43DB-A001-AF85FED98E5BQ36897349-46D43C6C-7B63-493F-A7C3-FE840543C1A8Q37546888-DA68D1BF-8DB5-49A0-A5DB-A3F9718027FAQ37838100-D93242AF-559C-4A84-904C-C7436D39E124Q38005318-7169E2A1-59DD-4FD6-8966-762A70B67C3FQ38211477-5EED1A7F-791A-4BE8-97D7-156A97553D46Q38688827-63FC3236-A0E1-4356-8BF6-672F7502237DQ38697027-7BBEDF0F-3FA5-451F-BF43-258130837A54Q38870495-A7E9AF63-CA43-43C0-B8A7-63A1767633E5Q39005117-83E5F1A9-2EB0-498A-9847-0457B6823510Q39627523-D682B0E4-6CAD-40A1-B997-3C5C1449D70AQ39662493-065D4385-FDAD-4A53-B6D0-08BF4DA49A96
P2860
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Clinical pharmacokinetics of the salicylates.
@en
Clinical pharmacokinetics of the salicylates.
@nl
type
label
Clinical pharmacokinetics of the salicylates.
@en
Clinical pharmacokinetics of the salicylates.
@nl
prefLabel
Clinical pharmacokinetics of the salicylates.
@en
Clinical pharmacokinetics of the salicylates.
@nl
P1476
Clinical pharmacokinetics of the salicylates.
@en
P2093
P304
P356
10.2165/00003088-198510020-00004
P577
1985-03-01T00:00:00Z
P6179
1000634957